Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
2 Tampilan
• 07/29/23
0
0
Menanamkan
administrator
Pelanggan
Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru